I particularly agree with your last statement that...

I particularly agree with your last statement that cardio-protection and SPP could have drained their resources since last week of November. However not with your statements that “melanoma animal data is trivial”- if it was, it wouldn’t be a milestone mentioned in the AGM pack.

We don’t expect a patent filing to be reported (like in the past) as a separate Ann.

To be clear, I am not insinuating anything against the mgmt but just confirming if I correctly understood the timing of expected news and wondering if market was going to be informed of any delays.

Some time in January we will get a quarterly update which should touch on all work in this quarter and hopefully delays would be resolved and we will receive Anns prior to the quarterly report.